Supriya Lifescience confident of 20% plus revenue growth in FY26
The company has begun supplying vitamin B2 under an exclusive 10-year contract with DSM Firmenich, expected to generate ₹30–35 crore in 2025-26 and ₹75–80 crore annually at peak by 2026-27 (FY27).

What's Your Reaction?






